Inadequate vasculature in solid tumours: consequences for cancer research strategies

Area of Science:

• Oncology
• Vascular Biology
• Cancer Therapeutics

Background:

• Antiproliferating endothelial therapy has emerged as a significant approach in cancer treatment over the past decade.
• Vascular effects, previously unrecognized, have been observed with various agents, impacting tumor growth.
• These vascular effects can complement or solely account for anticancer activity.

Purpose of the Study:

• To highlight the importance of monitoring and understanding the mechanisms of vascular effects in cancer therapy.
• To emphasize the need for optimized clinical scheduling of therapies targeting tumor vasculature.
• To re-evaluate current tumor models and therapeutic strategies, considering targeting nutrient supply via neovasculature.

Main Methods:

• Review of existing literature on antiproliferating endothelial therapy and its associated vascular effects.
• Analysis of diverse agents exhibiting vascular effects, including hyperthermia, photodynamic therapy, and biological agents.
• Discussion on the interplay between molecular biology approaches and the pathophysiology of tumor vasculature.

Main Results:

• Vascular effects are induced by a wide range of agents, some unrelated to direct tumor cell cytotoxicity.
• The efficacy of antiproliferating endothelial therapy depends on understanding its mechanism and optimizing treatment schedules.
• Current research necessitates a shift in focus from solely targeting tumor cells to targeting the tumor's nutrient supply through neovasculature.

Conclusions:

• Further research is crucial to elucidate the complex differences between tumor and normal vasculature.
• Careful consideration of therapeutic agent scheduling and appropriate model selection is vital to avoid premature rejection of potentially effective treatments.
• Targeting tumor vasculature represents a promising avenue for developing novel and effective anticancer therapies.